Elite athletic competitions have separate male and female events due to men's physical
advantages in strength, speed, and endurance so that a protected female category with …

Background Evidence regarding functional hypogonadism, previously referred to as 'late‐
onset'hypogonadism, has increased substantially during the last 10 year. Objective To …

Abstract Objective To update the “Testosterone Therapy in Men With Androgen Deficiency
Syndromes” guideline published in 2010. Participants The participants include an Endocrine …

Context The present summary of the European Association of Urology (EAU) guidelines is
based on the latest guidelines on male sexual health published in March 2021, with a last …

Background Testosterone is the standard treatment for male hypogonadism, but there is
uncertainty about its cardiovascular safety due to inconsistent findings. We aimed to provide …

Obesity is an emerging condition, with a prevalence of~ 20%. Although the simple
measurement of BMI is likely a simplistic approach to obesity, BMI is easily calculated, and …

The hypothalamic–pituitary–gonadal axis is of relevance in many processes related to the
development, maturation and ageing of the male. Through this axis, a cascade of …

Multiple changes occur across various endocrine systems as an individual ages. The
understanding of the factors that cause age-related changes and how they should be …

Male hypogonadism (MH) is a common endocrine disorder. However, uncertainties and
variations in its diagnosis and management exist. There are several current guidelines on …

Abstract The Testosterone Trials (TTrials) were a coordinated set of seven placebo-
controlled, double-blind trials in 788 men with a mean age of 72 years to determine the …